FDA/CDC

CDC awards $1.2 million to learn about people with sickle cell disease


 

The Centers for Disease Control and Prevention will be awarding $1.2 million in funding to help states collect data on issues faced by people with sickle cell disease.

CDC News icon

Currently, only Georgia and California work with the CDC on the Sickle Cell Data Collection program to gather population-based, comprehensive health information about people with sickle cell disease. The new funding will expand that base to nine states. The money will go toward a 1-year project that will build infrastructure for recipient sites to gather unique data and conduct in-depth analyses in people with sickle cell disease, the CDC noted.

The sites that were awarded funding are Duke University, Durham, N.C.; Georgia State University, Atlanta; the Indiana Hemophilia and Thrombosis Center in Indianapolis; the Michigan Department of Health & Human Services; the Minnesota Department of Health; the Public Health Institute in Oakland, Calif.; the University of Alabama at Birmingham; the University of Tennessee Health Science Center in Memphis; and the Virginia Department of Health.

“Data is vital to informing new treatments and clinical care that will improve the lives of people affected by sickle cell disease. This new funding expands CDC’s partner network across the country which will accelerate efforts to ensure sickle cell patients live longer and healthier lives,” said CDC Director Robert R. Redfield, MD.

Find the full press release on the CDC website.

Recommended Reading

Noninvasive prenatal test may detect sickle cell disease
MDedge Hematology and Oncology
Sickle cell unit running 24/7 reduces readmissions, emergency visits
MDedge Hematology and Oncology
Hemoglobin levels are associated with long-term dementia risk
MDedge Hematology and Oncology
Timing, volume of transfusion may not matter in children with severe anemia
MDedge Hematology and Oncology
Two iron chelators better than one for thalassemia major
MDedge Hematology and Oncology
Quercetin may reduce iron overload in beta-thalassemia major
MDedge Hematology and Oncology
Mitapivat elicits positive response in pyruvate kinase deficiency
MDedge Hematology and Oncology
Can we eradicate malaria by 2050?
MDedge Hematology and Oncology
U.S. and African programs aim to improve understanding, treatment of sickle cell disease
MDedge Hematology and Oncology
Novel gene therapies show promise for sickle cell cure
MDedge Hematology and Oncology